Table of Content

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Site Management Organizations
3.3. Role of Site Management Organizations in Clinical Trials
3.4. Services Offered by Site Management Organizations
3.5. Advantages of One-Stop-Shops
3.6. Concluding Remarks

4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Site Management Organizations: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Service(s) Offered
4.2.5. Analysis by Therapeutic Expertise
4.2.6. Analysis by Geographical Reach

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Site Management Organizations: Company Competitiveness Analysis
5.4.1. Competitiveness Analysis: Site Management Organizations in North America
5.4.1.1. Competitiveness Analysis: Small Companies in North America
5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
5.4.1.3. Competitiveness Analysis: Large Companies in North America
5.4.2. Competitiveness Analysis: Site Management Organizations in Europe
5.4.2.1. Competitiveness Analysis: Small Companies in Europe
5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
5.4.2.3. Competitiveness Analysis: Large Companies in Europe
5.4.3. Competitiveness Analysis: Site Management Organizations in Asia-Pacific and Rest of the World
5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World

6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FOMAT Medical Research
6.2.1. Company Overview
6.2.2. Clinical Trial Site Management Services
6.2.3. Recent Developments and Future Outlook
6.3. Parexel
6.3.1. Company Overview
6.3.2. Clinical Trial Site Management Services
6.3.3. Recent Developments and Future Outlook
6.4. Pharm-Olam
6.4.1. Company Overview
6.4.2. Clinical Trial Site Management Services
6.4.3. Recent Developments and Future Outlook
6.5. Veristat
6.5.1. Company Overview
6.5.2. Clinical Trial Site Management Services
6.5.3. Recent Developments and Future Outlook
6.6. WCCT Global
6.6.1. Company Overview
6.6.2. Clinical Trial Site Management Services
6.6.3. Recent Developments and Future Outlook
6.7. Worldwide Clinical Trials
6.7.1. Company Overview
6.7.2. Clinical Trial Site Management Services
6.7.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE
7.1. Chapter Overview
7.2. CROMSOURCE
7.2.1. Company Overview
7.2.2. Clinical Trial Site Management Services
7.2.3. Recent Developments and Future Outlook
7.3. Fidelis Research
7.3.1. Company Overview
7.3.2. Clinical Trial Site Management Services
7.3.3. Recent Developments and Future Outlook
7.4. Scandinavian CRO
7.4.1. Company Overview
7.4.2. Clinical Trial Site Management Services
7.4.3. Recent Developments and Future Outlook
7.5. TFS HealthScience
7.5.1. Company Overview
7.5.2. Clinical Trial Site Management Services
7.5.3. Recent Developments and Future Outlook
7.6. Trialbee
7.6.1. Company Overview
7.6.2. Clinical Trial Site Management Services
7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. CMIC Group
8.2.1. Company Overview
8.2.2. Clinical Trial Site Management Services
8.2.3. Recent Developments and Future Outlook
8.3. George Clinical
8.3.1. Company Overview
8.3.2. Clinical Trial Site Management Service
8.3.3. Recent Developments and Future Outlook
8.4. Tigermed
8.4.1. Company Overview
8.4.2. Clinical Trial Site Management Services
8.4.3. Recent Developments and Future Outlook
8.5. Veeda Clinical Research
8.5.1. Company Overview
8.5.2. Clinical Trial Site Management Services
8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Site Management Organizations: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Region-wise Distribution
9.3.6.2. Country-wise Distribution

10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Types of Funding
10.3. Site Management Organizations: Funding and Investment Analysis
10.3.1. Analysis by Year of Investment
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Year-wise Analysis by Type of Funding and Amount Invested
10.3.5. Most Active Players: Analysis by Number of Funding Instances
10.3.6. Most Active Investors: Analysis by Number of Funding Instances
10.3.7. Analysis by Type of Investor
10.3.8. Analysis by Geography

11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Site Management Organizations: Clinical Trial Key Insights
11.3.1. Analysis by Trial Registration Year
11.3.2. Analysis by Trial Registration Year and Enrolled Patient Population
11.3.3. Analysis by Trial Status
11.3.4. Analysis by Trial Registration Year and Trial Status
11.3.5. Analysis by Trial Phase
11.3.6. Analysis by Trial Phase and Enrolled Patient Population
11.3.7. Analysis by Trial Registration Year and Trial Phase (in term of Number of Clinical Trials)
11.3.8. Analysis by Trial Registration Year and Trial Phase (in terms of Number of Enrolled Patient Population)
11.3.9. Analysis by Type of Sponsor / Collaborator
11.3.10. Geographical Analysis by Number of Clinical Trials
11.3.11. Geographical Analysis by Enrolled Patient Population

12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
12.1. Chapter Overview
12.2. Methodology and Key Assumptions
12.3. Global Demand for Clinical Trial Participants: Analysis by Enrolled Patient Population
12.3.1. Analysis of Demand by Trial Phase
12.3.2. Analysis of Demand by Therapeutic Area
12.3.3. Geographical Demand by Enrolled Patient Population
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Global Site Management Organizations Market, 2021-2035
13.4. Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area
13.5. Site Management Organizations Market, 2021-2035: Distribution by Trial Phase
13.6. Site Management Organizations Market, 2021-2035: Distribution by Clinical Trial Components
13.7. Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention
13.8. Site Management Organizations Market, 2021 and 2035: Distribution by Region
13.8.1. Site Management Organizations Market, 2021 and 2035: Distribution by Country
13.8.2. Site Management Organizations Market in North America, 2021-2035
13.8.2.1. Site Management Organizations Market in the US, 2021-2035
13.8.2.2. Site Management Organizations Market in Canada, 2021-2035
13.8.2.3. Site Management Organizations Market in Rest of North America, 2021-2035
13.8.3. Site Management Organizations Market in Europe, 2021-2035
13.8.3.1. Site Management Organizations Market in the UK, 2021-2035
13.8.3.2. Site Management Organizations Market in France, 2021-2035
13.8.3.3. Site Management Organizations Market in Germany, 2021-2035
13.8.3.4. Site Management Organizations Market in Spain, 2021-2035
13.8.3.5. Site Management Organizations Market in Italy, 2021-2035
13.8.3.6. Site Management Organizations Market in Rest of Europe, 2021-2035
13.8.4. Site Management Organizations Market in Asia-Pacific, 2021-2035
13.8.4.1. Site Management Organizations Market in China, 2021-2035
13.8.4.2. Site Management Organizations Market in Korea, 2021-2035
13.8.4.3. Site Management Organizations Market in India, 2021-2035
13.8.4.4. Site Management Organizations Market in Australia, 2021-2035
13.8.4.5. Site Management Organizations Market in Japan, 2021-2035
13.8.4.6. Site Management Organizations Market in Israel, 2021-2035
13.8.4.7. Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035
13.8.5. Site Management Organizations Market in Latin America, 2021-2035
13.8.6. Site Management Organizations Market in MENA, 2021-2035
13.8.7. Site Management Organizations Market in Rest of the World, 2021-2035

14. CONCLUDING REMARKS

15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. GDD Experts
15.2.1. Company Snapshot
15.2.2. Interview Transcript: Vinod Gyanchandani, Country Head-Clinical Operations
15.3. SMO – Dra. Marisa Vico
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Marisa Vico, Medical Director and Operations Manager
15.4. Syncretic Clinical Research Services
15.4.1. Company Snapshot
15.4.2. Interview Transcript: Eugene Winifred, Project Manager

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS